Purpose
|
LDN193189(DM 3189) is a selective BMP signaling inhibitor, inhibits the transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM, respectively, exhibits 200-fold selectivity for BMP versus TGF-β.
|
Characteristics
|
Target: TGF-beta/Smad inhibitor Receptor: ALK2/3
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C25H22N6
|
Solubility
|
DMSO ≥4mg/mL, Water ≥30mg/mL
|